Diversification of the pharmaceutical and quasi-drug product strategy through making ノーエチ薬品 a wholly owned subsidiary
An M&A theme centered on making ノーエチ薬品 a wholly owned subsidiary through オカムラ, thereby expanding into OTC drugs and quasi-drugs in addition to the dental-related business to diversify and differentiate the product strategy.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.